Form 8-K - Current report:
SEC Accession No. 0001641172-25-010895
Filing Date
2025-05-15
Accepted
2025-05-15 16:07:44
Documents
16
Period of Report
2025-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 44515
2 EX-99.1 ex99-1.htm EX-99.1 66946
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4669
  Complete submission text file 0001641172-25-010895.txt   349316

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rnxt-20250515.xsd EX-101.SCH 3260
5 XBRL DEFINITION FILE rnxt-20250515_def.xml EX-101.DEF 26190
6 XBRL LABEL FILE rnxt-20250515_lab.xml EX-101.LAB 35952
7 XBRL PRESENTATION FILE rnxt-20250515_pre.xml EX-101.PRE 24848
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5193
Mailing Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040
Business Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 25952892
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)